fosinopril has been researched along with Proteinuria in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (40.91) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Craig, JC; Hahn, D; Hodson, EM | 1 |
| Gao, R; Li, G; Li, X; Wen, Y; Yue, C | 1 |
| Agrawal, A; Dubey, GP; Ghosh, B; Rajak, M; Singh, RG | 1 |
| Dai, B; Lv, J; Mei, C; Wang, Y; Xue, C; Yang, B; Yu, S; Zhao, G; Zhou, C | 1 |
| Cong, H; Sheng, Y; Xu, J | 1 |
| Deng, JL; Hou, YB; Li, J; Wang, H; Yue, J | 1 |
| Lan, H; Li, P; Liang, Q; Lu, J; Luo, G; Wang, Y; Yin, T; Zhang, H; Zhang, X; Zhao, T | 1 |
| Chen, X; Hong, Q; Shi, S; Wang, J; Wei, R; Yamanaka, N; Zhang, W | 1 |
| Dang, XQ; He, QN; He, XJ; Li, Z; Wu, XC; Yi, Z | 1 |
| Burczynski, FJ; Gong, Y; Li, P; Sun, Y; Yan, J | 1 |
| Basi, S; Fesler, P; Lewis, JB; Mimran, A | 1 |
| Batlle, D; Keilani, T; Schlueter, W | 1 |
| Cagnoli, L; Claroni, F; Fusaroli, M; Maschio, G; Rugiu, C; Sanna, G; Sasdelli, M; Zuccalà, A; Zucchelli, P | 1 |
| Burns, GC; Davis, I; Matute, R; Onyema, D; Toth, I | 1 |
| Batlle, DC; Keilani, T; Schlueter, W | 1 |
| Batlle, DC; Keilani, T; Levin, ML; Schlueter, WA | 1 |
| Burns, GC; Paul, SK; Sivak, SL; Toth, IR | 1 |
| Galimany, R; Higueruelo, S; Pastor, C; Romero, R; Vaquero, M | 1 |
| Bleck, JS; Brunkhorst, R; Ehlerding, G; Eisenberger, U; Hamkens, A; Kliem, V; Lufft, V; Maschek, H; Petersen, R; Pichlmayr, R | 1 |
| Bonnet, F; Burrell, LM; Cao, Z; Cooper, ME; Gilbert, RE; Tikkanen, I | 1 |
| Ferrari, P; Frey, FJ; Marti, HP; Pfister, M | 1 |
| Bochicchio, T; Bordes, J; Herrera-Acosta, J; Pérez-Grovas, H; Ron, O; Sandoval, G | 1 |
5 review(s) available for fosinopril and Proteinuria
| Article | Year |
|---|---|
Interventions for preventing and treating kidney disease in IgA vasculitis.
Topics: Adult; Child; Fosinopril; Humans; IgA Vasculitis; Kidney Diseases; Leflunomide; Proteinuria; Tacrolimus; Vasculitis | 2023 |
Prostaglandin E1 for preventing the progression of diabetic kidney disease.
Topics: Albuminuria; Alprostadil; Diabetic Nephropathies; Disease Progression; Drugs, Chinese Herbal; Fosinopril; Humans; Losartan; Proteinuria; Randomized Controlled Trials as Topic; Vasodilator Agents | 2010 |
Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?
Topics: Albuminuria; Antihypertensive Agents; Biomarkers; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Fosinopril; Glomerular Filtration Rate; Humans; Hypertension; Prevalence; Proteinuria | 2008 |
Selected aspects of ACE inhibitor therapy for patients with renal disease: impact on proteinuria, lipids and potassium.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Fosinopril; Humans; Lipids; Lipoproteins; Potassium; Proteinuria; Renin-Angiotensin System | 1995 |
Metabolic effects of converting enzyme inhibitors: focus on the reduction of cholesterol and lipoprotein(a) by fosinopril.
Topics: Black People; Cholesterol; Diabetes Complications; Double-Blind Method; Fosinopril; Humans; Hypertension; Kidney Diseases; Lipoprotein(a); Proteinuria; Time Factors | 1993 |
9 trial(s) available for fosinopril and Proteinuria
| Article | Year |
|---|---|
Comparative evaluation of fosinopril and herbal drug Dioscorea bulbifera in patients of diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Diabetic Nephropathies; Dioscorea; Disease Progression; Female; Fosinopril; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phytotherapy; Plant Extracts; Prospective Studies; Proteinuria | 2013 |
Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; China; Dihydropyridines; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Fosinopril; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Research Design; Treatment Outcome; Young Adult | 2017 |
[Efficacy of fosinopril on proteinuria in children with Henoch-Schonlein purpura nephritis].
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Child; Child, Preschool; Female; Fosinopril; Humans; IgA Vasculitis; Male; Nephritis; Proteinuria | 2009 |
Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Child; Drug Resistance; Drug Therapy, Combination; Female; Fosinopril; Glucocorticoids; Humans; Male; Nephrotic Syndrome; Peptidyl-Dipeptidase A; Prednisolone; Proteinuria; Renin | 2006 |
ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study.
Topics: Adolescent; Adult; Blood Pressure; Double-Blind Method; Female; Fosinopril; Glomerulonephritis, IGA; Humans; Male; Middle Aged; Proteinuria | 1994 |
Metabolic effects of converting enzyme inhibitors: focus on the reduction of cholesterol and lipoprotein(a) by fosinopril.
Topics: Black People; Cholesterol; Diabetes Complications; Double-Blind Method; Fosinopril; Humans; Hypertension; Kidney Diseases; Lipoprotein(a); Proteinuria; Time Factors | 1993 |
Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor.
Topics: Adult; Aged; Analysis of Variance; Blood Pressure; Double-Blind Method; Female; Fosinopril; Humans; Hypercholesterolemia; Hyperlipidemias; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Proteinuria | 1993 |
Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy.
Topics: AIDS-Associated Nephropathy; Angiotensin-Converting Enzyme Inhibitors; Creatinine; Female; Fosinopril; HIV-1; Humans; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; Time Factors | 1997 |
Fosinopril prevents hyperfiltration and decreases proteinuria in post-transplant hypertensives.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Female; Fosinopril; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney Transplantation; Male; Prodrugs; Proline; Proteinuria | 1990 |
9 other study(ies) available for fosinopril and Proteinuria
| Article | Year |
|---|---|
Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Antiphospholipid; Biopsy; Chi-Square Distribution; Disease Progression; Female; Follow-Up Studies; Fosinopril; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Logistic Models; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Proportional Hazards Models; Proteinuria; Renin-Angiotensin System; Risk Factors; Statistics, Nonparametric; Treatment Outcome; Young Adult | 2018 |
Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Fosinopril; Gas Chromatography-Mass Spectrometry; Humans; Hypertrophy; Kidney Cortex; Male; Metabolomics; Proteinuria; Rats; Rats, Wistar; Toxins, Biological | 2012 |
Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antigen-Antibody Complex; Blood Pressure; Chronic Disease; DNA; DNA-Binding Proteins; Female; Fosinopril; Glomerulonephritis, Membranoproliferative; Immunohistochemistry; Kidney; Phosphorylation; Proteinuria; Rats; Rats, Wistar; STAT3 Transcription Factor; Tissue Inhibitor of Metalloproteinase-1; Trans-Activators | 2005 |
Chinese herbal formula Qilong-Lishui granule improves puromycin aminonucleoside-induced renal injury through regulation of bone morphogenetic proteins.
Topics: Animals; Blood Proteins; Blood Urea Nitrogen; Bone Morphogenetic Protein Receptors, Type II; Bone Morphogenetic Proteins; Cholesterol; Creatinine; Drugs, Chinese Herbal; Fosinopril; Kidney; Microscopy, Electron; Nephrotic Syndrome; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Smad1 Protein; Triglycerides | 2007 |
Response to inhibition of angiotensin-converting enzyme in human immunodeficiency virus-associated nephropathy: a case report.
Topics: Adult; AIDS-Associated Nephropathy; Female; Fosinopril; Humans; Proteinuria | 1994 |
Fosinopril ameliorates exogenous cholesterol-induced incipient glomerular lesions in obese Zucker rats. Effects on eicosanoid secretion.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cholesterol; Cholesterol, Dietary; Eicosanoids; Fosinopril; Kidney Glomerulus; Obesity; Proteinuria; Rats; Rats, Zucker | 1998 |
Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage.
Topics: Angiotensin-Converting Enzyme Inhibitors; Female; Fosinopril; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Proteinuria | 1998 |
Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Blood Pressure; Creatinine; Disease Models, Animal; Fosinopril; Glomerular Filtration Rate; Heart Failure; Hypertension, Renal; Kidney; Male; Nephrectomy; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Proteinuria; Pyridines; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Renin; Thiazepines; Urea | 2001 |
Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Creatinine; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fosinopril; Humans; Irbesartan; Male; Middle Aged; Potassium; Proteinuria; Receptors, Angiotensin; Tetrazoles; Treatment Outcome | 2002 |